Lori McKenna Gorski
Directeur/Bestuurslid bij Our Odyssey, Inc.
Actieve functies van Lori McKenna Gorski
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Our Odyssey, Inc. | Directeur/Bestuurslid | - | - |
Loopbaan van Lori McKenna Gorski
Eerdere bekende functies van Lori McKenna Gorski
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CYCLO THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Public Communications Contact | 09-03-2011 | - |
RADIUS HEALTH, INC. | Public Communications Contact | - | - |
THERMO FISHER SCIENTIFIC | Public Communications Contact | - | - |
Opleiding van Lori McKenna Gorski
Boston College | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
Operationeel
Public Communications Contact | 3 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
THERMO FISHER SCIENTIFIC | Health Technology |
CYCLO THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Our Odyssey, Inc. |
- Beurs
- Insiders
- Lori McKenna Gorski
- Ervaring